Inventor · disambiguated record
John R. Jacobsen
Also filed as: JACOBSEN JOHN R
69 granted patents·12 pending applications·974 citations·filing 1999–2022
99Inventor score
Files withTHERAVANCE INC203M INNOVATIVE PROPERTIES CO11THERAVANCE BIOPHARMA R&D IP LLC10THERAVANCE RESPIRATORY CO LLC10DICE ALPHA INC6
Top patents by PatentIndex Score
81 records- 0199US6653323B2Aryl aniline β2 adrenergic receptor agonistsTHERAVANCE INC·Filed 2002·Granted Nov 25, 2003·100 cites·23 claims
- 0298US10526330B2JAK kinase inhibitor compounds for treatment of respiratory diseaseTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Jan 7, 2020·15 cites·13 claims
- 0398US10100049B2JAK kinase inhibitor compounds for treatment of respiratory diseaseTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2016·Granted Oct 16, 2018·28 cites·17 claims
- 0498US6797718B2Ether substituted imidazopyridines3M INNOVATIVE PROPERTIES CO·Filed 2003·Granted Sep 28, 2004·212 cites·22 claims
- 0598US6670376B1Aryl aniline β2 adrenergic receptor agonistsTHERAVANCE INC·Filed 2002·Granted Dec 30, 2003·129 cites·40 claims
- 0697US7622508B28-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonistsTHERAVANCE INC·Filed 2007·Granted Nov 24, 2009·39 cites·19 claims
- 0797US7220758B2Ether substituted imidazopyridines3M INNOVATIVE PROPERTIES CO·Filed 2006·Granted May 22, 2007·68 cites·33 claims
- 0895US7125890B2Ether substituted imidazopyridines3M INNOVATIVE PROPERTIES CO·Filed 2004·Granted Oct 24, 2006·67 cites·15 claims
- 0994US10913740B2JAK kinase inhibitor compounds for treatment of respiratory diseaseTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Feb 9, 2021·5 cites·18 claims
- 1094US9663509B28-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonistsLONG DANIEL D·Filed 2015·Granted May 30, 2017·10 cites·2 claims
- 1194US8263618B28-azabicyclo[3.2.1]octane compounds as MU opioid receptor antagonistsLONG DANIEL D·Filed 2009·Granted Sep 11, 2012·18 cites·15 claims
- 1293US11299492B2JAK kinase inhibitor compounds for treatment of respiratory diseaseTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2021·Granted Apr 12, 2022·2 cites·13 claims
- 1393US8664242B28-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonistsLONG DANIEL D·Filed 2012·Granted Mar 4, 2014·13 cites·6 claims
- 1493US6949568B2Aryl aniline β2 adrenergic receptor agonistsTHERAVANCE INC·Filed 2003·Granted Sep 27, 2005·23 cites·11 claims
- 1592US9394275B2Diamide compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2015·Granted Jul 19, 2016·7 cites·11 claims
- 1692US9206172B28-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonistsLONG DANIEL D·Filed 2014·Granted Dec 8, 2015·10 cites·2 claims
- 1792US8927573B28-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonistsLONG DANIEL D·Filed 2014·Granted Jan 6, 2015·10 cites·15 claims
- 1891US10745394B28-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonistsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Aug 18, 2020·2 cites·11 claims
- 1991US10081626B28-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonistsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2017·Granted Sep 25, 2018·5 cites·7 claims
- 2091US9803114B2Acrylic adhesive composition with controlled molecular weight3M INNOVATIVE PROPERTIES CO·Filed 2015·Granted Oct 31, 2017·4 cites·19 claims
- 2191US9682957B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2016·Granted Jun 20, 2017·5 cites·2 claims
- 2291US9572802B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2016·Granted Feb 21, 2017·5 cites·30 claims
- 2391US9000173B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityHUGHES ADAM D·Filed 2014·Granted Apr 7, 2015·7 cites·5 claims
- 2491US8816088B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityTHERAVANCE INC·Filed 2013·Granted Aug 26, 2014·7 cites·1 claims
- 2591US8138345B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityHUGHES ADAM·Filed 2010·Granted Mar 20, 2012·13 cites·3 claims
- 2690US9975875B2Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2017·Granted May 22, 2018·4 cites·3 claims
- 2790US8551978B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityHUGHES ADAM D·Filed 2012·Granted Oct 8, 2013·7 cites·6 claims
- 2889US11274094B2Substituted benzenecarboxamides as IL-17A modulatorsDICE ALPHA INC·Filed 2020·Granted Mar 15, 2022·2 cites·60 claims
- 2989US10377751B28-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonistsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Aug 13, 2019·3 cites·2 claims
- 3089US9771350B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2017·Granted Sep 26, 2017·4 cites·2 claims
- 3189US6355637B1Local anesthetic compoundsADVANCED MEDICINE INC·Filed 2000·Granted Mar 12, 2002·35 cites·25 claims
- 3288US11548887B28-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonistsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2020·Granted Jan 10, 2023·1 cites·16 claims
- 3388US7947710B2Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonistsTHERAVANCE INC·Filed 2008·Granted May 24, 2011·9 cites·15 claims
- 3486US8268863B2Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonistsSAITO DAISUKE ROLAND·Filed 2011·Granted Sep 18, 2012·8 cites·17 claims
- 3586US7902221B2Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonistsTHERAVANCE INC·Filed 2008·Granted Mar 8, 2011·10 cites·14 claims
- 3685US7582765B2Aryl aniline β2 adrenergic receptor agonistsTHERAVANCE INC·Filed 2007·Granted Sep 1, 2009·2 cites·16 claims
- 3785US7125892B2Aryl aniline β2 adrenergic receptor agonistsTHERAVANCE INC·Filed 2003·Granted Oct 24, 2006·16 cites·4 claims
- 3885US2023183232A18-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonistsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2022·Application pending·0 cites
- 3984US8518966B2Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonistsLONG DANIEL D·Filed 2011·Granted Aug 27, 2013·6 cites·19 claims
- 4084US8106232B23-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonistsTRAPP SEAN G·Filed 2008·Granted Jan 31, 2012·5 cites·17 claims
- 4184US8101791B2Aminotetralin compounds as mu opioid receptor antagonistsLEADBETTER MICHAEL R·Filed 2008·Granted Jan 24, 2012·5 cites·16 claims
- 4283US9695343B2Hot melt processable pressure sensitive adhesives containing fibrous materialsSATRIJO ANDREW·Filed 2011·Granted Jul 4, 2017·6 cites·20 claims
- 4381US10138220B1Diamide compounds having muscarinic receptor antagonis and beta2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2018·Granted Nov 27, 2018·1 cites·26 claims
- 4481US8314128B2Aminotetralin compounds as mu opioid receptor antagonistsLEADBETTER MICHAEL R·Filed 2011·Granted Nov 20, 2012·4 cites·9 claims
- 4581US7399863B2Amino-substituted ethylamino β2 adrenergic receptor agonistsTHERAVANCE INC·Filed 2004·Granted Jul 15, 2008·12 cites·13 claims
- 4680US7622467B2Aryl aniline derivatives as β2 adrenergic receptor agonistsTHERAVANCE INC·Filed 2005·Granted Nov 24, 2009·3 cites·16 claims
- 4779US11718616B2JAK kinase inhibitor compounds for treatment of respiratory diseaseTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2022·Granted Aug 8, 2023·0 cites·7 claims
- 4878US11447468B2IL-17 ligands and uses thereofDICE ALPHA INC·Filed 2020·Granted Sep 20, 2022·1 cites·17 claims
- 4976US10208232B2Adhesive composition3M INNOVATIVE PROPERTIES CO·Filed 2014·Granted Feb 19, 2019·1 cites·5 claims
- 5076US9890301B2Water-based pressure-sensitive adhesive compositions3M INNOVATIVE PROPERTIES CO·Filed 2015·Granted Feb 13, 2018·1 cites·15 claims
Showing the top 50 of 81 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when John R. Jacobsen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →